Results 111 to 120 of about 6,317 (201)

Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study. [PDF]

World Allergy Organ J
Canonica GW, Senna G, Brussino L, Aliani M, Altieri E, Bracciale P, Caiaffa MF, Cameli P, Caminati M, Caruso C, Centanni S, De Michele F, Del Giacco S, Di Marco F, Malerba L, Menzella F, Rogliani P, Romagnoli M, Schino P, Schroeder JW, Vultaggio A, D'Amato M, Pelaia G.   +22 more
europepmc   +1 more source

Real-World Effectiveness Following Benralizumab Use in Patients with Severe Eosinophilic Asthma in Romania: A Retrospective Cohort Study (BREEZE). [PDF]

J Clin Med
Toma CL, Teodorescu G, Mihălţan FD, Frent S, Ali S, Trenchea M, Constantin AA.   +6 more
europepmc   +1 more source

The pediatric asthma yardstick: Practical recommendations for a sustained step-up in asthma therapy for children with inadequately controlled asthma [PDF]

, 2018
Bacharier, Leonard B, Chipps, Bradley E, Farrar, Judith R, Jackson, Daniel J, Murphy, Kevin R, Phipatanakul, Wanda, Szefler, Stanley J, Teague, W. Gerald, Zeiger, Robert S   +8 more
core   +2 more sources

Benralizumab: Bringing winds of change to eosinophil-associated diseases. [PDF]

World Allergy Organ J
Korn S, Bleecker ER, Bourdin A, McCrae C, Jison ML, Menzies-Gow A.   +5 more
europepmc   +1 more source

Successful Treatment of Steroid-Dependent Severe Eosinophilic Pneumonia With Benralizumab: A Case Report. [PDF]

Respirol Case Rep
Ichikawa T, Takigawa Y, Fujiwara K, Inoue T, Matsumoto S, Shiraha K, Goda M, Matsuoka S, Watanabe H, Kudo K, Sato A, Sato K, Shibayama T.   +12 more
europepmc   +1 more source

Unmasking EGPA with near fatal diffuse alveolar haemorrhage in severe eosinophilic asthma under treatment with benralizumab: a case report. [PDF]

BMC Pulm Med
Drick N, Kaireit TF, Ruwisch J, Schallhorn S, Bauersachs J, Schenk H, Hoeper MM, Witte T, Seeliger B.   +8 more
europepmc   +1 more source

Comparative analysis of the manufacturing carbon footprint of biologics for severe asthma. [PDF]

BMJ Open
Taylor H, Rahman N.
europepmc   +1 more source

Real-world outcomes after anti-IL-5/anti-IL-5Rα treatment for hypereosinophilic syndrome: Systematic literature review. [PDF]

J Allergy Clin Immunol Glob
Jain P, Rowell J, Edmonds C, Stokes M, Ding N, Chen SY.   +5 more
europepmc   +1 more source

Case Report: A potential novel treatment for drug-induced acute interstitial nephritis: Benralizumab. [PDF]

Front Immunol
Saadia A, Wald R, Potruch A, Pizov G, Meir K, Gorin K, Sarig I, Dori EB, Rubin L, Ribak Y, Shamriz O, Tal Y, Talmon A.   +12 more
europepmc   +1 more source

Can Coexisting Allergic Rhinitis in Patients with Severe Eosinophilic Asthma Be a Prognostic Factor for Efficacy of Biological Therapy? Analysis of Eosinophilic Involvement. [PDF]

J Clin Med
Jura-Szołtys E, Glück J, Klimek L, Gawlik R.   +3 more
europepmc   +1 more source